Use of photoaffinity labels as P2-purinoceptor antagonists
Public Domain
-
1985/01/01
-
Details
-
Personal Author:
-
Description:There are both disadvantages and advantages to the use of the photoaffinity label ANAPP3 in the study of P2 receptors. The most obvious disadvantage is that ANAPP3 cannot be used as an irreversible antagonist in vivo, because there is no mechanism, at present, to irradiate the compound under these conditions. Related to this is the potential difficulty of photolyzing ANAPP3 in vitro if relatively thick tissue preparations are being investigated. The novelty of dealing with photoaffinity compounds, as well as the unusual apparatus, such as the lamps that are required, may seem to be a disadvantage as well. In spite of these difficulties, however, ANAPP3 is an important tool for investigators interested in the pharmacology and physiology of adenine nucleotides and nucleosides. ANAPP3 has the advantage of being the only specific antagonist of responses mediated through P2 receptors. Thus, the compound is of considerable value in probing the potential physiological role of ATP and in helping to distinguish between responses mediated by ATP and by adenosine. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISBN:9780306418723
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:279-292
-
NIOSHTIC Number:nn:20040958
-
Citation:Methods Used in Adenosine Research (Methods in Pharmacology. Volume 6). Paton DM, ed., New York: Plenum Press, 1985 Jan; 6:279-292
-
Editor(s):
-
Federal Fiscal Year:1985
-
Peer Reviewed:False
-
Source Full Name:Methods Used in Adenosine Research (Methods in Pharmacology. Volume 6)
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b534d2aadcaff9e756d2f7f5371d2ee401dc8c76ac353a9f0990887f808bca07b014b81f4c0242a38d228e5ed5c9728398d203e29a71ca6de8e2e0ef8dd0f834
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like